Time trends in testicular cancer in Croatia 1983-2007: Rapid increases in incidence, no declines in mortality

Cancer Epidemiology

Volumn 36, Issue 1, 2012, Pages 11-15

  Sincic, Nino ^a   Kulis, Tomislav ^b   Znaor, Ariana ^a,c   Bray, Freddie ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Croatia; Incidence; Mortality; Testicular cancer; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; CROATIA; DEATH; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; TESTIS CANCER;

ADOLESCENT; ADULT; CROATIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 84855843831     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.09.010     Document Type: Article

References (39)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase no. 10 [Internet] 2010, International Agency for Research on Cancer, Lyon, France, Available from: http://globocaniarcfr.
2. Purdue M.P., Devesa S.S., Sigurdson A.J., McGlynn K.A. International patterns and trends in testis cancer incidence. Int J Cancer 2005, 115(5):822-827.
3. Bray F., Richiardi L., Ekbom A., Pukkala E., Cuninkova M., Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006, 118(12):3099-3111.
4. Holmes L., Escalante C., Garrison O., Foldi B.X., Ogungbade G.O., Essien E.J., et al. Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?. Public Health 2008, 122(9):862-872.
5. McGlynn K.A., Devesa S.S., Sigurdson A.J., Brown L.M., Tsao L., Tarone R.E. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003, 97(1):63-70.
6. Matsuda T., Saika K. Comparison of time trends in testicular cancer incidence (1973-97) in East Asia, Europe and USA, from cancer incidence in five continents, vols. IV-VIII. Jpn J Clin Oncol 2008, 38(8):578-579.
7. Baade P., Carriere P., Fritschi L. Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 2008, 19(10):1043-1049.
8. Garner M.J., Turner M.C., Ghadirian P., Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005, 116(3):331-339.
9. Lind G.E., Skotheim R.I., Lothe R.A. The epigenome of testicular germ cell tumors. APMIS 2007, 115(10):1147-1160.
10. Schulz W.A., Hoffmann M.J. Transcription factor networks in embryonic stem cells and testicular cancer and the definition of epigenetics. Epigenetics 2007, 2(1):37-42.
11. Korkola J.E., Heck S., Olshen A.B., Reuter V.E., Bosl G.J., Houldsworth J., et al. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer 2008, 47(1):43-55.
12. Walsh T.J., Croughan M.S., Schembri M., Chan J.M., Turek P.J. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009, 169(4):351-356.
13. Weir H.K., Marrett L.D., Kreiger N., Darlington G.A., Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000, 87(3):438-443.
14. Cook M.B., Akre O., Forman D., Madigan M.P., Richiardi L., McGlynn K.A. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer - experiences of the mother. Int J Epidemiol 2009, 38(6):1532-1542.
15. Cook M.B., Akre O., Forman D., Madigan M.P., Richiardi L., McGlynn K.A. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer - experiences of the son. Int J Epidemiol 2010, 39(6):1605-1618.
16. Huddart R.A. Survival from testicular cancer in England and Wales up to 2001. Br J Cancer 2008, 99(Suppl. 1):S83-S85.
17. Einhorn L.H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977, 87(3):293-298.
18. Dearnaley D., Huddart R., Horwich A. Regular review: managing testicular cancer. BMJ 2001, 322(7302):1583-1588.
19. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999 Results and commentary. Eur J Cancer 2009, 45(6):931-991.
20. Cancer incidence in five continents, vol. IX 2007, IARC, Lyon, [IARC Scientific Publications No. 160].
21. Cancer incidence in five continents, vol. VII 1997, IARC, Lyon, [IARC Scientific Publications No. 143].
22. Cancer incidence in five continents, vol. VIII 2002, IARC, Lyon, [IARC Scientific Publications No. 155].
23. Doll R., Payne P., Waterhouse J. Cancer incidence in five continents: a technical report 1966, Springer, New York.
24. Cancer mortality for selected sites in 24 countries (1950-1957) 1960, Tohoku University of Medicine, Sendai. 2nd ed. M. Segi, M. Kurihara (Eds.).
25. National Cancer Institute Joinpoint regression program. 3.4.2 ed. 2009, Statistical Research and Applications Branch, National Cancer Institute, Bethesda.
26. Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19(3):335-351.
27. Clayton D., Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987, 6(4):469-481.
28. Clayton D., Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987, 6(4):449-467.
29. Bergstrom R., Adami H.O., Mohner M., Zatonski W., Storm H., Ekbom A., et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996, 88(11):727-733.
30. Bray F., Ferlay J., Devesa S.S., McGlynn K.A., Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 2006, 3(10):532-543.
31. Pike M.C., Chilvers C.E., Bobrow L.G. Classification of testicular cancer in incidence and mortality statistics. Br J Cancer 1987, 56(1):83-85.
32. Richiardi L., Bellocco R., Adami H.O., Torrang A., Barlow L., Hakulinen T., et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004, 13(12):2157-2166.
33. Jacobsen R., Moller H., Thoresen S.O., Pukkala E., Kjaer S.K., Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 2006, 29(1):199-204.
34. Chia V.M., Quraishi S.M., Devesa S.S., Purdue M.P., Cook M.B., McGlynn K.A. International Trends in the Incidence of Testicular Cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010, 19(5):1151-1159.
35. Oosterhuis J.W., Looijenga L.H. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005, 5(3):210-222.
36. Bray F., Richiardi L., Ekbom A., Forman D., Pukkala E., Cuninkova M., et al. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 2006, 15(4):652-658.
37. Bertuccio P., Malvezzi M., Chatenoud L., Bosetti C., Negri E., Levi F., et al. Testicular cancer mortality in the Americas, 1980-2003. Cancer 2007, 109(4):776-779.
38. Boyle P. Testicular cancer: the challenge for cancer control. Lancet Oncol 2004, 5(1):56-61.
39. Harding M.J., Paul J., Gillis C.R., Kaye S.B. Management of malignant teratoma: does referral to a specialist unit matter?. Lancet 1993, 341(8851):999-1002.